Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.870
-0.120 (-4.01%)
Apr 17, 2026, 4:08 PM HKT
Luye Pharma Group Revenue
In the year 2025, Luye Pharma Group had annual revenue of 6.31B CNY with 4.07% growth. Luye Pharma Group had revenue of 3.13B in the half year ending December 31, 2025, a decrease of -3.45%.
Revenue
6.31B CNY
Revenue Growth
+4.07%
P/S Ratio
1.63
Revenue / Employee
1.23M CNY
Employees
5,115
Market Cap
11.46B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.31B | 246.93M | 4.07% |
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition